Title |
Human induced pluripotent stem cell for modeling cardiovascular diseases
|
---|---|
Published in |
Regenerative Medicine Research, February 2014
|
DOI | 10.1186/2050-490x-2-4 |
Pubmed ID | |
Authors |
Ping Liang, Jie Du |
Abstract |
The invention of the induced pluripotent stem cell (iPSC) technology allows patient-specific, mature somatic cells to be converted into an unlimited supply of pluripotent stem cells (PSCs). These iPSCs can then in turn be differentiated into any cell type including neurons, cardiac cells, pancreatic cells, liver cells, blood cells or enterocytes. Although cardiovascular disease (CVD) is a leading cause of death in the world, the limited cell derivation and cell number in cardiac tissue makes it difficult to study the CVDs using the existing cardiac cell model. By differentiating the patient-specific iPSCs into cardiomyocytes, scientists can generate iPSC-based 'disease in a dish' models and use them to better understand disease mechanism. Here we review the current progress in using iPSC-derived cardiomyocytes to model human CVDs. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Germany | 1 | 33% |
Unknown | 2 | 67% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 5% |
Germany | 1 | 2% |
Unknown | 38 | 93% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 8 | 20% |
Student > Ph. D. Student | 7 | 17% |
Student > Bachelor | 6 | 15% |
Student > Master | 6 | 15% |
Professor | 3 | 7% |
Other | 5 | 12% |
Unknown | 6 | 15% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 13 | 32% |
Biochemistry, Genetics and Molecular Biology | 8 | 20% |
Medicine and Dentistry | 5 | 12% |
Engineering | 4 | 10% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 5% |
Other | 4 | 10% |
Unknown | 5 | 12% |